Insights into the development of preneoplastic metaplasia: Spasmolytic polypeptide-expressing Metaplasia and Oxyntic atrophy

The Biology of Gastric Cancers

Volumn , Issue , 2009, Pages 361-375

  Goldenring, James R ^a   Nomura, Sachiyo ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84874113510     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-69182-4_13     Document Type: Chapter

References (61)

1. Biankin, A.V., J.G. Kench, F.P. Dijkman, S.A. Biankin, and S.M. Henshall. 2003. Molecular pathogenesis of precursor lesions of pancreatic ductal adenocarcinoma. Pathology. 35:14-24.
2. Blaser, M. 1992. Hypotheses on the pathogenesis and natural history of Helicobacter pyloriinduced inflammation. Gastroenterology. 102:720-727.
3. Blaser, M., and J. Parsonnet. 1994. Parasitism by the slow bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest. 94:4-8.
4. Borch, K., H Renvall, and G. Liedberg. 1985. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 88:638-648.
5. Brito, M.J., M.I Filipe, J. Linehan, and J. Jankowski. 1995. Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barretts epithelium: biological and clinical variables. Int J Cancer. 60:27-32.
6. Burdick, J.S., E. Chung, G. Tanner, M. Sun, J.E. Paciga, J.Q. Cheng, K. Washington, J.R. Goldenring, and R.J. Coffey. 2000. Treatment of Menetriers disease with a monoclonal antibody against the epidermal growth factor receptor. N Engl J Med. 343:1697-1701.
7. Cameron, A.J., C.T. Lomboy, M. Pera, and H.A. Carpenter. 1995. Adenocarcinoma of the esophagogastric junction and Barretts esophagus. Gastroenterology. 109:1541-1546.
8. Cameron, A.J., B.J. Ott, and W.S. Payne. 1985. The incidence of adenocarcinoma in columnarlined (Barretts) esophagus. New Engl J Med. 313:857-859.
9. Canfield, V.A., A.B. West, J.R. Goldenring, and R. Levenson. 1996. Targeted ablation of parietal cells in transgenic mice. Proc Natl Acad Sci USA. 93(6):2431-2435.
10. Coffey, R.J., R. Derynck, J.N. Wilcox, T.S. Bringman, A.S. Goustin, H.L. Moses, and M.R. Pittelkow. 1987. Production and auto-induction of TGF alpha in human keratinocytes. Nature. 328:817-820.
11. Correa, P. 1988. A human model of gastric carcinogenesis. Cancer Res. 48:3554-3560.
12. Courtois-Coutry, N., D. Rousch, V. Rajendran, J.B. McCarthy, J. Geibel, M. Kashgarian, and M.J. Caplan. 1997. A tyrosine-based signal targets H/K-ATPase to a regulated compartment and is required for the cessation of gastric acid secretion. Cell. 90:501-510.
13. Dempsey, P.J., J.R. Goldenring, C.J. Soroka, I.M. Modlin, R.W. McClure, C.D. Lind, D.A. Ahlquist, M.R. Pittlekow, D.C. Lee, E.P. Sandgren, D.L. Page, and R.J. Coffey. 1992. Possible role of TGFa in the pathogenesis of Menetriers disease: supportive evidence from humans and transgenic mice. Gastroenterology. 103:1950-1963.
14. Dhar, D.K., T.C. Wang, R. Maruyama, J. Udagawa, H Kubota, T. Fuji, M. Tachibana, T. Ono, H Otani, and N. Nagasue. 2003. Expression of cytoplasmic TFF2 is a marker of tumor metastasis and negative prognostic factor in gastric cancer. Lab Invest. 83:1343-1352.
15. El-Zimaity, H.M.T., H Ota, D.Y. Graham, T. Akamatsu, and T. Katsuyama. 2002. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 94:1428-1436.
16. Filipe, M.I., N. Munoz, I Matko, I Kato, V. Pompe-Kirn, A. Juersek, S. Teuchmann, M. Benz, and T. Prijon. 1994. Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer. 57:324-329.
17. Fox, J.G., M. Blanco, J.C. Murphy, N.S. Taylor, A. Lee, Z. Kabok, and J. Pappo. 1993. Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun. 61:2309-2315.
18. Fox, J.G., X. Li, R.J. Cahill, K. Andrutis, A.K. Rustgi, R. Odze, and T.C. Wang. 1996. Hypertrophic gastropathy in Helicobacter felis-infected wild type C57BL/6 mice and p53 hemizygous transgenic mice. Gastroenterology. 110:155-166.
19. Fox, J.G., T.C. Wang, A.B. Rogers, T. Poutahidis, Z. Ge, N. Taylor, C.A. Dangler, D.A. Israel, U. Krishna, K. Gaus, and R.M. Peek, Jr. 2003. Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology. 124:1879-1890.
20. Goldenring, J.R., and S. Nomura. 2006. Differentiation of the gastric mucosa III Animal models of oxyntic atrophy and metaplasia. Am J Physiol Gastrointest Liver Physiol. 291:G999-1004.
21. Goldenring, J.R., G.S. Ray, R.J. Coffey, P.C. Meunier, P.J. Haley, T.B. Barnes, and B.D. Car. 2000. Reversible drug-induced oxyntic atrophy in rats. Gastroenterology. 118:1080-1093.
22. Halldorsdottir, A.M., M. Sigurdardottir, J.G. Jonasson, M. Oddsdottir, J. Magnusson, J.R. Lee, and J.R. Goldenring. 2003. Spasmolytic polypeptide expressing metaplasia (SPEM) associated with gastric cancer in Iceland. Dig Dis Sci. 48:431-441.
23. Hattori, T. 1986. Development of adenocarcinomas in the stomach. Cancer. 57:1528-1534.
24. Hattori, T., and S. Fujita. 1979. Tritiated thymidine autoradiographic study on histogenesis and spreading of intestinal metaplasia in human stomach. Pathol Res Pract. 164:224-237.
25. Hattori, T., B. Helpap, and P. Gedigk. 1982. The morphology and cell kinetics of pseudopyloric glands. Virchows Arch B Cell Pathol Incl Mol Pathol. 39:31-40.
26. Houghton, J., C. Stoicov, S. Nomura, J. Carlson, H Li, A.B. Rogers, J.G. Fox, J.R. Goldenring, and T.C. Wang. 2004. Gastric cancer originating from bone marrow derived cells. Science. 306:1568-1571.
27. Katz, J.P., N. Perreault, B.G. Goldstein, L. Actman, S.R. McNally, D.G. Silberg, E.E. Furth, and K.H Kaestner. 2005. Loss of Klf4 in mice causes altered proliferation and differentiation and precancerous changes in the adult stomach. Gastroenterology. 128:935-945.
28. Kirchner, T., S. Muller, T. Hattori, K. Mukaisyo, T. Papadopoulos, T. Brabletz, and A. Jung. 2001. Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchows Arch. 439:512-522.
29. Konda, Y., H Kamimura, H Yokota, N. Hayashi, K. Sugano, and T. Takeuchi. 1999. Gastrin stimulates the growth of gastric pit with less-differentiated features. Am J Physiol. 277: G773-784.
30. Leys, C.M., S. Nomura, E. Rudzinski, M. Kaminishi, E. Montgomery, M.K. Washington, and J.R. Goldenring. 2006. Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol. 37:1162-1168.
31. Li, Q., S.M. Karam, and J.I Gordon. 1996. Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem. 271:3671-3676.
32. Lopez-Diaz, L., K.L. Hinkle, R.N. Jain, Y. Zavros, C.S. Brunkan, T. Keeley, K.A. Eaton, J.L. Merchant, C.S. Chew, and L.C. Samuelson. 2006. Parietal cell hyperstimulation and autoimmune gastritis in cholera toxin transgenic mice. Am J Physiol Gastrointest Liver Physiol. 290: G970-979.
33. Marshall, A.C., F. Alderuccio, K. Murphy, and B.H Toh. 2005. Mechanisms of gastric mucosal cell loss in autoimmune gastritis. Int Rev Immunol. 24:123-134.
34. Means, A.L., I.M. Meszoely, K. Suzuki, Y. Miyamoto, A.K. Rustgi, R.J. Coffey, Jr., C.V. Wright, D.A. Stoffers, and S.D. Leach. 2005. Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development. 132:3767-3776.
35. Mutoh, H., Y. Hakamata, K. Sato, A. Eda, I Yanaka, S. Honda, H Osawa, Y. Kaneko, and K. Sugano. 2002. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Commun. 294:470-479.
36. Nam, K.T., A. Varro, R.J. Coffey, and J.R. Goldenring. 2007. Potentiation of oxyntic atrophyinduced gastric metaplasia in amphiregulin-deficient mice. Gastroenterology. 132:1804-1819.
37. Nomura, S., S.H Settle, C. Leys, A.L. Means, R.M. Peek, Jr., S.D. Leach, C.V.E. Wright, R.J. Coffey, and J.R. Goldenring. 2005. Evidence for repatterning of the gastric fundic epithelium associated with Menetriers disease and TGFa overexpression. Gastroenterology. 128:1292-1305.
38. Nomura, S., H Yamaguchi, T.C. Wang, J.R. Lee, and J.R. Goldenring. 2004. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild type and gastrin deficient mice. Am J Physiol. 288:G362-G375.
39. Nozaki, K., M. Ogawa, J.A. Williams, B.J. LaFleur, V. Ng, R.I Drapkin, J.C. Mills, S.F. Konieczny, S. Nomura, and J.R. Goldenring. 2008. A molecular signature of gastric metaplasia arising in response to acute parietal cell loss. Gastroenterology. 134(2):511-522.
40. Ogawa, T., K. Maeda, S. Tonai, T. Kobayashi, T. Watanabe, and S. Okabe. 2003. Utilization of knockout mice to examine the potential role of gastric histamine H2-receptors in Menetriers disease. J Pharmacol Sci. 91:61-70.
41. Ogawa, M., S. Nomura, B.D. Car, and J.R. Goldenring. 2006a. Omeprazole treatment ameliorates oxyntic atrophy induced by DMP-777. Dig Dis Sci. 51:431-439.
42. Ogawa, M., S. Nomura, A. Varro, T.C. Wang, and J.R. Goldenring. 2006b. Altered metaplastic response of waved-2 EGF receptor mutant mice to acute oxyntic atrophy. Am J Physiol Gastrointest Liver Physiol. 290:G793-804.
43. Ormand, J.E., N.J. Talley, R.G. Shorter, C.R. Conley, H.A. Carpenter, A. Fich, W.R. Wilson, and S.F. Phillips. 1991. Prevalence of Helicobacter pylori in specific forms of gastritis: further evidence supporting a pathogenic role for H pylori in chronic nonspecific gastritis. Dig Dis Sci. 36:142-145.
44. Oshima, M., H Oshima, A. Matsunaga, and M.M. Taketo. 2005. Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-Alphadependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice. Cancer Res. 65:9147-9151.
45. Parsonnet, J., G.D. Friedman, D.P. Vandersteen, Y. Chang, J.H Vogelman, N. Orentreich, and R.K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric cancer. New Engl J Med. 325:1127-1131.
46. Peura, D.A. 1997. The report of the Digestive Health Initiative international update conference on Helicobacter pylori. Gastroenterology. 113:S4-S8.
47. Pisani, P., D.M. Parkin, F. Bray, and J. Ferlay. 1999. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 83:18-29.
48. Rembacken, B., T. Fujii, and H Kondo. 2001. The recognition and endoscopic treatment of early gastric and colonic cancer. Best Pract Res Clin Gastroenterol. 15:317-336.
49. Schmidt, P.H., J.R. Lee, V. Joshi, R.J. Playford, R. Poulsom, N.A. Wright, and J.R. Goldenring. 1999. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest. 79:639-646.
50. Sharp, R., M.W. Babyatsky, H Takagi, S. Tagerud, T.C. Wang, D.E. Bockman, S.E. Brand, and G. Merlino. 1995. Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development. 121:149-161.
51. Silberg, D.G., J. Sullivan, E. Kang, G.P. Swain, J. Moffett, N.J. Sund, S.D. Sackett, and K.H Kaestner. 2002. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology. 122:689-696.
52. Takizawa, T., and M. Koike. 1998. Minute gastri carcinoma from pathomorphological aspect-reconsideration concerning histogenesis of gastric carcinomas. Stomach Intestine. 23:791-800.
53. Wainess, R.M., J.B. Dimick, G.R. Upchurch, Jr., J.A. Cowan, and M.W. Mulholland. 2003. Epidemiology of surgically treated gastric cancer in the United States, 1988-2000. J Gastrointest Surg. 7:879-883.
54. Wang, T.C., C.A. Dangler, D. Chen, J.R. Goldenring, T. Koh, R. Raychowdhury, R.J. Coffey, S. Ito, A. Varro, G.J. Dockray, and J.G. Fox. 2000. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 118:36-47.
55. Wang, T.C., J.R. Goldenring, C. Dangler, S. Ito, A. Mueller, W.K. Jeon, T.J. Koh, and J.G. Fox. 1998. Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology. 114:675-689.
56. Wolfsen, H.C., H.A. Carpenter, and N.J. Talley. 1993. Menetriers disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology. 104:1310-1319.
57. Wright, N.A., C. Pike, and G. Elia. 1990. Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature. 343:82-85.
58. Xia, H.H., J.S. Kalantar, N.J. Talley, J.M. Wyatt, S. Adams, K. Cheung, and H.M. Mitchell. 2000. Antral-type mucosa in the gastric incisura, body and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia. Am J Gastroenterol. 95:114-121.
59. Yamaguchi, H., J.R. Goldenring, M. Kaminishi, and J.R. Lee. 2001. Identification of spasmolytic polypeptide expressing metaplasia (SPEM) in remnant gastric cancer and surveillance postgastrectomy biopsies. Dig Dis Sci. 47:573-578.
60. Yamaguchi, H., J.R. Goldenring, M. Kaminishi, and J.R. Lee. 2002. Association of spasmolytic polypeptide expressing metaplasia (SPEM) with carcinogen administration and oxyntic atrophy in rats. Lab Invest. 82:1045-1052.
61. Yoshizawa, N., Y. Takenaka, H Yamaguchi, T. Tetsuya, H Tanaka, M. Tatematsu, S. Nomura, J.R. Goldenring, and M. Kaminishi. 2007. Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest. 87:1265-1276